 Management to host conference call and webcast on August 13th at 5:00 pm EDT 2:00 pm PDTSAN DIEGO, Aug. 06, 2020 GLOBE NEWSWIRE -- aTyr Pharma, Inc. Nasdaq: LIFE, a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced that it will report second quarter 2020 financial results and provide a corporate update after the market close on Thursday, August 13, 2020. Conference Call and Webcast Details: Thursday, August 13th 5:00 p.m. EDT 2:00 p.m. PDT Domestic: 844-358-9116 International: 209-905-5951 Conference ID: 5176802 Webcast: aTyraTyr is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways. aTyrs research and development efforts are concentrated on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. aTyr has built a global intellectual property estate directed to a potential pipeline of protein compositions derived from 20 tRNA synthetase genes and their extracellular targets. aTyrs primary focus is ATYR1923, a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to down-regulate immune engagement in inflammatory lung diseases. For more information, please visit Contact: Ashlee Dunston Investor Relations, aTyr Pharma 